Operating cash flow
Flow – sum over the period · $M
Q3 2023
−0.3a$M
derived
All values (14)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 87.7 | derived |
| Q1 2026 | 74.6 | reported |
| Q4 2025 | 95.3 | derived |
| Q3 2025 | 78.2 | derived |
| Q2 2025 | 135.4 | derived |
| Q1 2025 | 10.5 | reported |
| Q4 2024 | 39.7 | derived |
| Q3 2024 | 63.5 | derived |
| Q2 2024 | 29.8 | derived |
| Q1 2024 | 3.7 | reported |
| Q4 2023 | 14.4 | derived |
| Q3 2023 | −0.3 | derived |
| Q2 2023 | −23.0 | derived |
| Q1 2023 | −3.8 | reported |
28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: ocf
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- −334,000 USD (derived)
- Period
- Q3 2023, ended Sep 30, 2023 · quarterly value (3 months, not cumulative)
- Calculation
- Q3 = 9 months kumuliert − 6 months kumuliert = −27M − −27M = $0.00 (us-gaap:NetCashProvidedByUsedInOperatingActivities; 9-Monats-Wert aus 0001736297-24-000043, Vorperiode aus dem vorherigen 10-Q)
- Source
- 10-Q, filed Nov 5, 2024 · 0001736297-24-000043
- Location
- us-gaap:NetCashProvidedByUsedInOperatingActivities
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | −334,000 USD | Nov 5, 2024 | 10-Q 0001736297-24-000043 | derived · confidence 1. · current |